| Polymorphonuclear leukocytes enhance release of growth factors by cultured endothelial cells. | |
| | |
MedLine Citation:
|
PMID: 8274467 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Porcine aortic endothelial cells (PAECs) in culture constitutively secrete polypeptide (endothelium-derived) growth factors (EDGFs) into the surrounding medium. Incubation of PAECs with human peripheral blood polymorphonuclear leukocytes (PMNs) caused a significant increase in EDGF release as assessed by [3H]thymidine incorporation into BALB/c 3T3 mouse fibroblasts and cell proliferation assay. The effect was time dependent and correlated with the number of PMNs, reaching a maximum with a 1:1 PAEC to PMN ratio. Generation of mitogenic activity was prevented by cycloheximide, indicating a requirement for de novo protein synthesis. Antibody-mediated inhibition assays suggested that mitogenic activity was due to platelet-derived growth factor and basic fibroblast growth factor. When supernatant from N-formyl-methionyl-leucyl-phenylalanine-stimulated PMNs was substituted for PMNs during incubation with PAECs, powerful mitogenic activity was generated, indicating the involvement of soluble mediators. A role for free oxygen radicals was ruled out by experiments in which superoxide dismutase and catalase did not prevent the increase in mitogenic activity. By contrast, serine protease inhibitors such as soybean trypsin inhibitor, alpha 1-antitrypsin, and eglin C reduced the PMN-stimulating activity by 70%, 80%, and 100%, respectively. The possible involvement of cathepsin G and elastase was investigated. Cathepsin G and elastase, when substituted for PMNs, increased the release of EDGFs in a dose-dependent fashion, mimicking the effect of PMNs. These findings suggest a new role for leukocyte-vessel wall interactions in the proliferative feature of atherosclerosis. |
| | |
Authors:
|
L Totani; A Piccoli; G Pellegrini; A Di Santo; R Lorenzet |
Related Documents
:
|
3893317 - Effects of aminoglycoside antibiotics on polymorphonuclear leukocyte function in vivo. 9063667 - Synergistic effect of azithromycin on the phagocytic killing of staphylococcus aureus b... 2043477 - Priming of normal human neutrophils by recombinant human growth hormone. 9058737 - Ceramide inhibits igg-dependent phagocytosis in human polymorphonuclear leukocytes. 21263017 - Lipoxin a₄ inhibits porphyromonas gingivalis-induced aggregation and reactive oxygen ... 5049427 - Ultrastructural characteristics of freeze-dried human blood platelets. |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association Volume: 14 ISSN: 1049-8834 ISO Abbreviation: Arterioscler. Thromb. Publication Date: 1994 Jan |
Date Detail:
|
Created Date: 1994-02-04 Completed Date: 1994-02-04 Revised Date: 2009-11-19 |
Medline Journal Info:
|
Nlm Unique ID: 9101388 Medline TA: Arterioscler Thromb Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 125-32 Citation Subset: IM |
Affiliation:
|
Antonio Taticchi Unit for Atheroselerosis and Thrombosis Research, Istituto di Ricerche Farmacologiche Mario Negri, Consorzio Mario Negri Sud, Santa Maria Imbaro, Italy. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Aorta Cathepsin G Cathepsins / pharmacology Cell Survival Cells, Cultured Endothelium, Vascular / cytology, secretion* Fibroblast Growth Factor 2 / secretion Free Radical Scavengers Growth Substances / secretion* Humans N-Formylmethionine Leucyl-Phenylalanine / pharmacology Neutrophils / physiology* Pancreatic Elastase / pharmacology Platelet-Derived Growth Factor / secretion Protease Inhibitors / pharmacology Reactive Oxygen Species Serine Endopeptidases Swine |
| Chemical | |
Reg. No./Substance:
|
0/Free Radical Scavengers; 0/Growth Substances; 0/Platelet-Derived Growth Factor; 0/Protease Inhibitors; 0/Reactive Oxygen Species; 103107-01-3/Fibroblast Growth Factor 2; 59880-97-6/N-Formylmethionine Leucyl-Phenylalanine; EC 3.4.-/Cathepsins; EC 3.4.21.-/Serine Endopeptidases; EC 3.4.21.20/CTSG protein, human; EC 3.4.21.20/Cathepsin G; EC 3.4.21.20/Ctsg protein, mouse; EC 3.4.21.36/Pancreatic Elastase |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Glycosaminoglycan fractions from human arteries presenting diverse susceptibilities to atheroscleros...
Next Document: ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree.